Copyright
©The Author(s) 2022.
World J Gastroenterol. Sep 14, 2022; 28(34): 4973-4992
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.4973
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.4973
Table 4 General characteristics and clinicopathological factors of gastric cancer patients and healthy control subjects
Variables | Gastric cancer (n = 15) | Healthy control (n = 15) |
Gender | ||
Male | 12 | 12 |
Female | 3 | 3 |
Age (yr) | ||
Mean | 61 | 62 |
Range | 48-70 | 47-80 |
Tumor site1 | ||
Upper third | 3 | - |
Middle third | 4 | - |
Lower third | 8 | - |
Tumor size | ||
≥ 5 cm | 6 | - |
< 5 cm | 9 | - |
Pathological differentiation2 | ||
Undifferentiated or poorly differentiated | 12 | - |
Others | 3 | - |
TNM classification3 | ||
I + II | 4 | - |
III + IV | 11 | - |
Lymphatic invasion3 | ||
Positive | 11 | - |
Negative | 4 | - |
- Citation: Zhuo ZL, Xian HP, Sun YJ, Long Y, Liu C, Liang B, Zhao XT. Long noncoding RNA ZNFX1-AS1 promotes the invasion and proliferation of gastric cancer cells by regulating LIN28 and CAPR1N1. World J Gastroenterol 2022; 28(34): 4973-4992
- URL: https://www.wjgnet.com/1007-9327/full/v28/i34/4973.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i34.4973